Labome logo
home > human > NF kappaB repressing factor inhibitor/activator/substrate/reporter | 1 product cited in the literature; 1 total from 1 supplier
Your Filters
product
  • Parthenolide
    Alomone Labs
    catalog: P-250
    citations: 1

    Western blot analysisof rat brain synaptosomal fraction (lanes 1 and 3) and mouse brain lysates (lanes 2 and 4): - 12.Anti-KCNK12(THIK-2)(extracellular)Antibody (#APC-169)(1:400).34. Anti-KCNK12 (THIK-2) (extracellular) Antibody preincubated with the negative control antigen.


    Alomone Labs Parthenolide inhibits the NF-?B pathway in Jurkat and HeLa cells. - Jurkat (A) and HeLa (B) cells were treated with different concentrations of Parthenolide (#P-250) for 1 h. Jurkat cells were then stimulated with 100 nM PMA (#P-800) and 1 M Ionomycin (#I-700) for 15 min. Hela cells were stimulated with 4000 U/ml TNF? for 10 min. Cell proteins were resolved by SDS-PAGE and probed with anti-phospho-p65 NF-?B.
    quantity:
    price:
    to the supplier
gene information - human NF kappaB repressing factor
    • synonym:ITBA4; NRF
    • description:NFKB repressing factor
do you know?
  • we limit the listing of re-branded antibodies to provide our visitors with accurate information and the best experience
  • we manually curate antibody information from the literature to obtain a comprehensive set of well-validated antibodies.
  • we limit citation information for polyclonal antibodies to articles published within the last 5 years because the supply of a particular polyclonal antibody preparation is limited.
product type
  • NF kappaB repressing factor chemical
  • NF kappaB repressing factor antibody
  • NF kappaB repressing factor gene knockdown
  • NF kappaB repressing factor cDNA
  • NF kappaB repressing factor protein
  • NF kappaB repressing factor other
related gene
  • heterogeneous nuclear ribonucleoprotein D like
  • XRN2
  • IL-8
  • DDX3
  • iNOS
  • ELANE
  • IFN-gamma
  • MMP-9
  • DHX15
  • p65
linkout
  • ncbi
  • review
questions and comments

 
Labome.com © 2025 All Rights Reserved
last updated:2025-08-30